Elevation of tumor necrosis factor alpha levels is associated with restless legs symptoms in clinically depressed patients

Restless legs syndrome is a sensorimotor disorder associated with several mental illnesses particularly depression. A cross-sectional study of primary care patients. The prevalence of restless legs symptoms was studied in 706 patients with depressive symptoms and 426 controls without a psychiatric d...

Full description

Saved in:
Bibliographic Details
Published inJournal of psychosomatic research Vol. 115; pp. 1 - 5
Main Authors Auvinen, Piritta, Mäntyselkä, Pekka, Koponen, Hannu, Kautiainen, Hannu, Korniloff, Katariina, Ahonen, Tiina, Vanhala, Mauno
Format Journal Article
LanguageEnglish
Published England Elsevier Inc 01.12.2018
Elsevier Science Ltd
Subjects
Online AccessGet full text
ISSN0022-3999
1879-1360
1879-1360
DOI10.1016/j.jpsychores.2018.09.008

Cover

Loading…
More Information
Summary:Restless legs syndrome is a sensorimotor disorder associated with several mental illnesses particularly depression. A cross-sectional study of primary care patients. The prevalence of restless legs symptoms was studied in 706 patients with depressive symptoms and 426 controls without a psychiatric diagnosis by using a structured questionnaire. The depressive symptoms were evaluated with the BDI and the psychiatric diagnosis was confirmed by means of a diagnostic interview (M.I.N.I.). The subjects with elevated depressive symptoms were divided into two groups subjects with depressive symptoms with and without clinical depression. The prevalence of restless legs symptoms was 24.8% in the controls, 50.0% in the patients with clinical depression and 42.4% in the patients with depressive symptoms. CRP value was significantly higher (p = .003) in the clinically depressed patients than in the other groups. There was a higher concentration of TNF-α in the subjects with restless legs symptoms (7.4 ng/l ± 3.2) compared with the subjects without symptoms (6.7 ng/l ± 2.3)(p < .001). There was a significant difference in the TNF-α levels between the subjects with and without restless legs symptoms in the depression group (p < .001) and among the patients with depressive symptoms but no a depression diagnosis (p = .022). In these groups, restless legs symptoms were associated with elevated levels of TNF-α. TNF-α level was associated with restless legs symptoms only among subjects with depressive symptoms whether they had clinical depression or not. We suggest that TNF-α could be an underlying factor between restless legs symptoms and comorbidities. •TNF-α was significantly higher in the depressed patients with restless legs symptoms.•CRP did not have a similar association to restless legs symptoms than TNF-α.•The clinically depressed patients had a higher plasma glucose values and CRP than the controls.•There was no noteworthy difference in the concentration of TNF-α between the controls and the depressive patients.
Bibliography:ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 14
content type line 23
ISSN:0022-3999
1879-1360
1879-1360
DOI:10.1016/j.jpsychores.2018.09.008